Propranolol Dosing for Migraine Prevention
The recommended starting dose of propranolol for migraine prevention is 80 mg per day, with a therapeutic range of 80-240 mg daily. 1, 2
Initial Dosing and Titration
- Start with a low dose and gradually increase to minimize side effects 1
- For the immediate-release formulation, begin with 80 mg daily divided into three doses 2
- For extended-release capsules, start with 80 mg once daily 3
- Titrate the dose gradually over several weeks until optimal migraine prophylaxis is achieved 1, 3
- Some patients may respond to doses as low as 1 mg/kg body weight daily 4
Therapeutic Dosing Range
- The effective dose range for migraine prevention is 80-240 mg per day 2, 1
- For extended-release formulations, the usual effective dose range is 160-240 mg once daily 3
- Clinical benefits may not become apparent for 2-3 months after reaching the target dose 2, 1
- If satisfactory response is not obtained within 4-6 weeks after reaching the maximal dose, consider discontinuing propranolol therapy 3
Administration Considerations
- When using extended-release capsules, administer once daily 3
- When using immediate-release tablets, divide the total daily dose into three equal doses 2
- If switching from immediate-release to extended-release formulations, retitration may be necessary to maintain effectiveness throughout the 24-hour dosing interval 3
Efficacy and Evidence
- Propranolol has strong evidence supporting its efficacy as a first-line agent for migraine prevention 2, 1
- In clinical trials, propranolol has demonstrated significant reduction in migraine frequency compared to placebo 5
- Approximately 73.5% of patients may respond to lower doses of propranolol (around 1 mg/kg/day) 4
- Propranolol appears more effective for pure migraine, while amitriptyline may be superior for mixed migraine and tension-type headache 2, 1
Common Side Effects and Monitoring
- Monitor for common adverse effects including dizziness, nausea, fatigue, depression, and insomnia 2, 1
- These side effects are generally well-tolerated by most patients 2
- Consider gradual withdrawal after a period of stability to avoid rebound symptoms 2, 3
Important Considerations
- Beta-blockers with intrinsic sympathomimetic activity are ineffective for migraine prevention and should be avoided 1
- Propranolol is contraindicated in patients with bradycardia or heart block 1
- If discontinuing treatment, reduce the dose gradually over several weeks to prevent rebound symptoms 3